Effects of metformin on inappropriate LH release in women with polycystic ovarian syndrome
and insulin resistance.
Vitamin D level in unmarried females with Polycystic ovarian syndrome
. JIIMC 2016; 11(2): 57-61.
Table 3 Acanthosis nigricans at different body areas in patients with polycystic ovarian syndrome
Effect of yoga nidra on resting cardiovascular parameters in polycystic ovarian syndrome
Association between polycystic ovarian syndrome
, overweight, and metabolic syndrome in adolescents.
Sattar, "Low grade chronic inflammation in women with polycystic ovarian syndrome
," The Journal of Clinical Endocrinology and Metabolism, vol.
Sovio et al., "Large-scale analysis of the relationship between CYP11A Promoter variation, polycystic ovarian syndrome
, and serum testosterone," The Journal of Clinical Endocrinology & Metabolism, vol.
Some doctors prescribe metformin (Glucophage) for treating prediabetes, particularly if there is a history of polycystic ovarian syndrome
, but this should not be a substitute for a healthy lifestyle.
Mean age, mean gravidity, mean parity and duration of sexual life in patients with polycystic ovarian syndrome
and the control group PCOS group Mean age (years) (mean + SD) 29.3[+ or -]5.2 (19-39) Mean gravidity (mean + SD) 1.7[+ or -]1.4 (1-5) Mean parity (mean + SD) 1.3[+ or -]1.1 (1-4) Duration of sexual lifea (mean + SD) 4.8[+ or -]3.6 years Control group p Mean age (years) (mean + SD) 27.9[+ or -]5.1 (21-35) 0.428 Mean gravidity (mean + SD) 2.5[+ or -]1.2 (0-4) 0.148 Mean parity (mean + SD) 1.8[+ or -]1.2 (0-4) 0.333 Duration of sexual lifea (mean + SD) 5.1[+ or -]3.1 years 0.778 (a) Duration of sexual life in years from initial coitus; p<0.05 PCOS: Polycystic ovarian syndrome
, SD: Standard deviation Table 2.
Rodent models of polycystic ovaries have shown many characteristics similar to that in the human polycystic ovarian syndrome
(PCOS) which includes hyper-androgenism, disrupted cyclicity, presence of follicular cysts/polycystic ovaries.5 Different androgens like Di-hydrotestosterone (DHT), estradiolvalerate, dehydro-epiandrosterone (DHEA), and testosterone were used to develop polycystic ovaries in rodents.5,6 In this study we used Testosterone propionate (TP) to develop a rodent model of the condition.
Polycystic Ovarian Syndrome
(PCOS) is a condition that causes irregular menstrual periods with excessive facial and body hair growth, acne, and/or male pattern scalp hair thinning.
Polycystic ovarian syndrome
(PCOS) is a very common endocrine system disorder affecting about 5-10% women of reproductive age.